Detalhe da pesquisa
1.
Economic burden associated with extrapyramidal symptoms in a medicaid population with schizophrenia.
Community Ment Health J
; 50(1): 51-8, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-23229052
2.
Resource utilization, costs and treatment patterns of switching and discontinuing treatment of MS patients with high relapse activity.
BMC Health Serv Res
; 13: 131, 2013 Apr 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-23565628
3.
Annual Cost Burden by Level of Relapse Severity in Patients with Multiple Sclerosis.
Adv Ther
; 38(1): 758-771, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33245532
4.
Impact of Switching to Fingolimod Versus Injectable Disease-Modifying Therapy Cycling on Risk of Multiple Sclerosis-Related Relapses: A Retrospective Analysis.
Int J MS Care
; 23(2): 73-78, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33880083
5.
Healthcare resource utilization, treatment patterns, and cost of care among patients with thermal burns and inpatient autografting in two large privately insured populations in the United States.
Burns
; 46(4): 825-835, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31761452
6.
Economic impact of biologic utilization patterns in patients with psoriatic arthritis.
Clin Rheumatol
; 36(7): 1579-1588, 2017 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-28474139
7.
Real-World Adherence and Persistence to Oral Disease-Modifying Therapies in Multiple Sclerosis Patients Over 1 Year.
J Manag Care Spec Pharm
; 23(8): 844-852, 2017 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-28737986
8.
Economic Impact of Above-Label Dosing with Etanercept, Adalimumab, or Ustekinumab in Patients with Psoriasis.
J Manag Care Spec Pharm
; 23(5): 583-589, 2017 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-28448778
9.
Difference-in-Differences Method in Comparative Effectiveness Research: Utility with Unbalanced Groups.
Appl Health Econ Health Policy
; 14(4): 419-429, 2016 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-27371369
10.
Evaluation of techniques for handling missing cost-to-charge ratios in the USA Nationwide Inpatient Sample: a simulation study.
J Comp Eff Res
; 4(5): 473-83, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-26387587
11.
Benefits of applying a proxy eligibility period when using electronic health records for outcomes research: a simulation study.
BMC Res Notes
; 8: 229, 2015 Jun 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-26055181
12.
Effects of GOLD-Adherent Prescribing on COPD Symptom Burden, Exacerbations, and Health Care Utilization in a Real-World Setting.
Chronic Obstr Pulm Dis
; 2(3): 223-235, 2015 Jun 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-28848845
13.
Assessing the importance of predictors in unplanned hospital readmissions for chronic obstructive pulmonary disease.
Clinicoecon Outcomes Res
; 7: 37-51, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25609986
14.
Economic Burden of COPD in the Presence of Comorbidities.
Chest
; 148(1): 138-150, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-25675282
15.
Group-based trajectory modeling to assess adherence to biologics among patients with psoriasis.
Clinicoecon Outcomes Res
; 6: 197-208, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24748809
16.
Erratum to: Benefits of applying a proxy eligibility period when using electronic health records for outcomes research: a simulation study.
BMC Res Notes
; 8: 340, 2015 Aug 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-26260056